BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17167787)

  • 1. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes.
    Striano P; Perruolo G; Errichiello L; Formisano P; Beguinot F; Zara F; Striano S
    Ann Neurol; 2008 Jan; 63(1):127-8. PubMed ID: 17167787
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum antibodies in epilepsy and seizure-associated disorders.
    McKnight K; Jiang Y; Hart Y; Cavey A; Wroe S; Blank M; Shoenfeld Y; Vincent A; Palace J; Lang B
    Neurology; 2005 Dec; 65(11):1730-6. PubMed ID: 16344514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.
    Solimena M; Folli F; Denis-Donini S; Comi GC; Pozza G; De Camilli P; Vicari AM
    N Engl J Med; 1988 Apr; 318(16):1012-20. PubMed ID: 3281011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?
    Blanc F; Ruppert E; Kleitz C; Valenti MP; Cretin B; Humbel RL; Honnorat J; Namer IJ; Hirsch E; Manning L; de Seze J
    J Neurol Sci; 2009 Dec; 287(1-2):69-71. PubMed ID: 19786284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association of type 1 diabetes mellitus and epilepsy in children. A cohort of 10 cases].
    Caietta E; Halbert C; Lépine A; Khammar A; Cano A; Gavaret M; Mancini J; Villeneuve N; Chabrol B; Simonin G; Reynaud R; Milh M
    Arch Pediatr; 2012 Jan; 19(1):9-16. PubMed ID: 22112607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment.
    Nociti V; Frisullo G; Tartaglione T; Patanella AK; Iorio R; Tonali PA; Batocchi AP
    Eur J Neurol; 2010 Jan; 17(1):e5. PubMed ID: 19906270
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies as predictors of type 1 diabetes.
    Wilkin TJ
    Compr Ther; 1991 Jul; 17(7):3-10. PubMed ID: 1742966
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody-phenotype correlation in stiff-person syndrome.
    Evoli A
    Neurology; 2008 Dec; 71(24):1938-9. PubMed ID: 18971446
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti glutamate-decarboxylase antibodies: a liaison between localisation related epilepsy, stiff-person syndrome and type-1 diabetes mellitus.
    Szűcs A; Barcs G; Winkler G; Soós Z; Folyovich A; Kelemen A; Várallyay P; Kamondi A
    Ideggyogy Sz; 2014 Jul; 67(7-8):269-71. PubMed ID: 25509368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stiff-man syndrome and type I diabetes mellitus: a common autoimmune pathogenesis?].
    Solimena M; Folli F
    Ann Ist Super Sanita; 1988; 24(4):583-6. PubMed ID: 3218808
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients.
    Errichiello L; Perruolo G; Pascarella A; Formisano P; Minetti C; Striano S; Zara F; Striano P
    J Neuroimmunol; 2009 Jun; 211(1-2):120-3. PubMed ID: 19428124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Auto-antibodies against glutamic acid decarboxylase and diabetes].
    Mandrup-Poulsen TR
    Ugeskr Laeger; 2007 Jan; 169(4):300-4. PubMed ID: 17274923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermittent prednisolone and autoantibodies to GAD65 in juvenile neuronal ceroid lipofuscinosis.
    Aberg L; Talling M; Härkönen T; Lönnqvist T; Knip M; Alen R; Rantala H; Tyynelä J
    Neurology; 2008 Apr; 70(14):1218-20. PubMed ID: 18378887
    [No Abstract]   [Full Text] [Related]  

  • 14. [Islet cell antibodies].
    Kobayashi T
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():390-4. PubMed ID: 12355779
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies in Type 1 diabetes.
    Schmidt KD; Valeri C; Leslie RD
    Clin Chim Acta; 2005 Apr; 354(1-2):35-40. PubMed ID: 15748597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An association between type 1 diabetes and idiopathic generalized epilepsy.
    Vulliemoz S; Seeck M
    Ann Neurol; 2006 Apr; 59(4):728. PubMed ID: 16566023
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes.
    Lernmark A
    J Clin Invest; 2002 Apr; 109(7):869-70. PubMed ID: 11927613
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction and prevention of type I diabetes.
    Eisenbarth GS; Gianani R; Pugliese A; Verge CF; Pietropaolo M
    Transplant Proc; 1994 Apr; 26(2):361-2. PubMed ID: 8171463
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence of diabetes-associated autoantibodies in schoolchildren: the Karlsburg Type 1 Diabetes Risk Study.
    Schlosser M; Strebelow M; Rjasanowski I; Kerner W; Wassmuth R; Ziegler M
    Ann N Y Acad Sci; 2004 Dec; 1037():114-7. PubMed ID: 15699502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M; Tavolato B; Giometto B
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.